Skip to main content
    R

    Replimune Group Inc (REPL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $19.69
    -1.72 (-8.03%)

    Market Cap: $2.03B

    Last updated: Nov 17, 2026 at 4:27 PM ET

    Replimune Group Inc (REPL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Replimune Group (REPL) has a market cap of $2.03B and an enterprise value of $1.84B. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 14.43% from a year earlier.

    Total Valuation

    Enterprise value is 9.19% below the market cap, as cash exceeds debt.

    Market Cap$2.03B
    Enterprise Value$1.84B
    Latest price (Nov 17, 2026)$19.69

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateOct 28, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count rose 8.58% in the quarter ended Sep 30, 2026 and grew 15.70% a year over 2 years.

    Shares Outstanding105.18M
    Shares Change (YoY)+14.43%
    Shares Change (QoQ)+8.58%
    Share Count Growth (2Y CAGR)+15.70%

    Valuation Ratios

    Forward P/S59.1x
    P/B Ratio10.1x

    Price Statistics

    The stock is up 119.02% over 52 weeks and trades 31.35% above its 50-day average.

    Beta (1Y)0.51
    52-Week Change+119.02%
    1-Month Change+78.19%
    3-Month Change+32.95%
    6-Month Change+318.94%
    5-Year Change-40.33%
    Total Return (1Y)+119.02%
    Total Return (3Y CAGR)+23.70%
    Total Return (5Y CAGR)-10.06%
    Return vs SPY (1Y)+113.73%
    Max Drawdown (1Y)-84.16%
    Max Drawdown (3Y)-88.61%
    Sharpe Ratio (1Y)0.45
    Correlation with SPY (1Y)0.04
    50-Day Average$14.99
    200-Day Average$10.13
    52-Week Range$1.50 to $23.54
    RSI (14 Days)58.0
    Average Volume (20 Days)3.49M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.11x current liabilities, and total debt is 0.59x shareholder equity.

    Current Ratio7.11x
    Quick Ratio6.90x
    Debt / Equity0.59x
    Interest Coverage-24.58x

    Returns and Efficiency

    Return on invested capital is -65.35% and return on equity is -132.35% over the last 12 months.

    Return on Equity (ROE)-132.35%
    Return on Assets (ROA)-72.48%
    Return on Invested Capital (ROIC)-65.35%
    Return on Capital Employed (ROCE)-82.12%
    ROE (5Y Average)-73.22%
    ROA (5Y Average)-47.22%

    Scores

    REPL has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$269.73M
    Pretax Income-$271.58M
    Net Income-$271.03M
    EBITDA-$264.27M
    EBIT-$269.67M
    Reported EPS (TTM)-$2.79

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 54.76% of the $373.94M in total assets.

    Cash and Equivalents$307.83M
    Total Debt$121.22M
    Net Cash$186.62M
    Net Cash Per Share$1.77
    Working Capital$278.48M
    Shareholder Equity$204.78M
    Book Value Per Share$1.95
    Total Assets$373.94M
    Total Liabilities$169.16M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $223.00K of capital spending, operating cash flow left -$245.77M of free cash flow.

    Operating Cash Flow-$245.55M
    Capital Expenditures$223.00K
    Free Cash Flow-$245.77M
    FCF Per Share-$2.61
    Depreciation and Amortization$5.41M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-45.81%
    Tangible Book Per Share Growth (2Y CAGR)-45.81%

    Revenue and profit by year

    Dividends and Yields

    REPL does not pay a dividend. Its free cash flow yield is -11.87%.

    FCF Yield-11.87%
    Buyback Yield-1.50%
    Shareholder Yield-1.50%

    Peer Position

    Against 7 similar companies, REPL has the 7th highest ROIC.

    ROIC-65.35% vs -17.30% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs +40.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About REPL

    What is REPL's market cap?

    Replimune Group has a market cap of $2.03B. Its enterprise value, which adds debt and subtracts cash, is $1.84B.

    How many shares of REPL are outstanding?

    Replimune Group has 105.18M shares outstanding. The count is up 14.43% from a year earlier.

    Does REPL pay a dividend?

    No. Replimune Group does not pay a dividend.

    How much debt does REPL have?

    Replimune Group has $121.22M of total debt and $307.83M of cash and equivalents, a net cash position of $186.62M.